ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 896 filers reported holding ASTRAZENECA PLC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,121 | -8.3% | 16,548 | -3.1% | 0.08% | -6.0% |
| Q2 2023 | $1,222 | +3.1% | 17,079 | 0.0% | 0.08% | -2.4% |
| Q1 2023 | $1,185 | -13.8% | 17,079 | -15.7% | 0.08% | -17.5% |
| Q4 2022 | $1,374 | -99.9% | 20,265 | -2.4% | 0.10% | +14.4% |
| Q3 2022 | $1,138,000 | -10.6% | 20,759 | +7.8% | 0.09% | -7.2% |
| Q2 2022 | $1,273,000 | -0.4% | 19,265 | 0.0% | 0.10% | +10.2% |
| Q1 2022 | $1,278,000 | +13.9% | 19,265 | 0.0% | 0.09% | +17.3% |
| Q4 2021 | $1,122,000 | -8.6% | 19,265 | -5.7% | 0.08% | -17.6% |
| Q3 2021 | $1,227,000 | +252.6% | 20,433 | +193.1% | 0.09% | +203.3% |
| Q4 2020 | $348,000 | +19.6% | 6,971 | +31.4% | 0.03% | +20.0% |
| Q3 2020 | $291,000 | -7.3% | 5,304 | -10.6% | 0.02% | -19.4% |
| Q2 2020 | $314,000 | +18.5% | 5,936 | 0.0% | 0.03% | 0.0% |
| Q1 2020 | $265,000 | +754.8% | 5,936 | +814.6% | 0.03% | +287.5% |
| Q2 2010 | $31,000 | – | 649 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |